Alzheimer's Disease Clinical Trials

Showing 1921-1940 of 1,974 trials

Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects

NCT00684710

This study will provide an initial assessment of the safety, tolerability, and pharmacokinetics (PK) of PAZ-417 after administration of ascending single oral doses to healthy young Japanese male and healthy elderly Japanese male subjects.

Alzheimer DiseaseHealthy

Wyeth is now a wholly owned subsidiary of Pfizer56 participantsStarted Apr 2008

Kitashinagawa, Shinagawa-ku, Tokyo, Japan

COMPLETEDPhase 1

Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid

NCT00692705

The study is carried out in order to investigate if \[11C\]AZD2995, compared to \[11C\]AZD2184, is a more suitable PET ligand for in vivo imaging of β amyloid depositions in the human brain. In the study the two PET ligands will be examined in both healthy volunteers and patients with Alzheimer's Disease.

Alzheimer´s Disease

AstraZeneca13 participantsStarted Jan 2008

Stockholm, Sweden

COMPLETEDPhase 4

Electrophysiologic Measures of Treatment Response in Alzheimer Disease

NCT00018278

The main purpose of this study is to determine the electrophysiological effects of cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer disease. The attempt will be to locate electrophysiological markers and predictors of cognitive and clinical treatment response.

Alzheimer Disease

US Department of Veterans AffairsStarted Oct 1998

San Diego, California, United States

COMPLETEDPhase 2

Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

NCT00018343

This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.

Alzheimer's Disease

US Department of Veterans AffairsStarted Apr 1998

Lakewood, Washington, United States

Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects

Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid

Electrophysiologic Measures of Treatment Response in Alzheimer Disease

Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

Related Searches

Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease

Memantine Versus Donepezil in Early Stages of Alzheimer's Disease

Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.

Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Effect of Lithium and Divalproex in Alzheimer's Disease

PET Scan of Brain Metabolism in Relation to Age and Disease

Treatment of Alzheimer's Disease With CX516 (Ampalex)

Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia

Genetic Studies in Alzheimer's Disease